Trial Profile
Arresting Vertical Transmission of Hepatitis B Virus in the Democratic Republic of the Congo: The AVERT-HBV Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2021
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms AVERT-HBV
- 25 Aug 2020 Status changed from active, no longer recruiting to completed.
- 22 Nov 2019 Status changed from recruiting to active, no longer recruiting.
- 11 Oct 2018 Status changed from not yet recruiting to recruiting.